U.S. markets open in 6 hours 17 minutes

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
59.30-0.70 (-1.17%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
Operating Expense
49,526
35,678
12,781
5,554
Operating Income
-49,526
-35,678
-12,781
-5,554
Net Non Operating Interest Income Expense
1,638
3,351
270
0
Other Income Expense
46
2
-10
-4
Pretax Income
-47,842
-32,325
-12,521
-5,558
Net Income Common Stockholders
-47,842
-32,325
-12,521
-5,558
Diluted NI Available to Com Stockholders
-47,842
-32,325
-12,521
-5,558
Basic EPS
-
-0.0018
0
0
Diluted EPS
-
-0.0018
0
0
Basic Average Shares
-
17,971
12,785
12,785
Diluted Average Shares
-
17,971
12,785
12,785
Total Operating Income as Reported
-49,526
-35,678
-12,781
-5,554
Total Expenses
49,526
35,678
12,781
5,554
Net Income from Continuing & Discontinued Operation
-47,842
-32,325
-12,521
-5,558
Normalized Income
-47,842
-32,325
-12,521
-5,558
Interest Income
1,638
3,351
270
0
Net Interest Income
1,638
3,351
270
0
EBIT
-49,526
-35,678
-12,781
-5,554
EBITDA
-48,736
-
-
-
Reconciled Depreciation
790
450
214
113
Net Income from Continuing Operation Net Minority Interest
-47,842
-32,325
-12,521
-5,558
Normalized EBITDA
-48,736
-35,228
-12,567
-5,441
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0